Chaitan Khosla PhD - 13 Mar 2024 Form 3 Insider Report for First Wave BioPharma, Inc. (ENTO)

Role
Director
Signature
/s/ Chaitan Khosla
Issuer symbol
ENTO
Transactions as of
13 Mar 2024
Net transactions value
$0
Form type
3
Filing time
15 Mar 2024, 18:00:51 UTC
Next filing
12 Jun 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney